CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 89 filers reported holding CARDIFF ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,041 | -46.0% | 53,267 | -42.9% | 0.00% | – |
| Q2 2023 | $137,051 | +176.9% | 93,232 | +210.8% | 0.00% | – |
| Q1 2023 | $49,500 | +51.7% | 30,000 | +28.7% | 0.00% | – |
| Q4 2022 | $32,633 | +25.5% | 23,309 | +93.9% | 0.00% | – |
| Q2 2022 | $26,000 | -97.8% | 12,019 | -97.4% | 0.00% | -100.0% |
| Q1 2022 | $1,157,000 | -49.0% | 466,347 | +23.6% | 0.00% | -40.0% |
| Q4 2021 | $2,268,000 | -43.7% | 377,369 | -37.6% | 0.01% | -44.4% |
| Q3 2021 | $4,028,000 | -14.5% | 604,750 | -14.7% | 0.01% | -18.2% |
| Q2 2021 | $4,713,000 | -29.8% | 708,668 | -2.2% | 0.01% | -35.3% |
| Q1 2021 | $6,713,000 | +9.9% | 724,959 | +113.4% | 0.02% | -5.6% |
| Q4 2020 | $6,111,000 | – | 339,682 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |